{"filing":{"accession_number":"0001193125-26-335200","cik":"0001819253","ticker":"BTMD","company_name":"biote Corp.","form":"8-K","filing_date":"2026-08-05","report_date":"2026-08-05","primary_document":"btmd-20260805.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1819253/000119312526335200/btmd-20260805.htm"},"events":[{"id":24762,"run_id":22449,"accession_number":"0001193125-26-335200","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a clear earnings release for Q2 2026 ended June 30, 2026, disclosed via press release furnished as Exhibit 99.1 under Item 2.02. The filing reports quarterly financial results including revenue of $44.2 million, net loss of $(7.4) million, and revised full-year 2026 guidance. The disclosure is material as it reflects significant operational challenges from a voluntary product recall and represents a material change in financial performance (net loss vs. prior-year net income).","company_name":"biote Corp.","ticker":"BTMD","filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":[{"id":25427,"accession_number":"0001193125-26-335200","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release for Q2 2026 ended June 30, 2026, disclosed via press release furnished as Exhibit 99.1 under Item 2.02. The filing reports quarterly financial results including revenue of $44.2 million, net loss of $(7.4) million, and revised full-year 2026 guidance. The disclosure is material as it reflects significant operational challenges from a voluntary product recall and represents a material change in financial performance (net loss vs. prior-year net income).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T02:19:45.870686+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":25427,"accession_number":"0001193125-26-335200","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release for Q2 2026 ended June 30, 2026, disclosed via press release furnished as Exhibit 99.1 under Item 2.02. The filing reports quarterly financial results including revenue of $44.2 million, net loss of $(7.4) million, and revised full-year 2026 guidance. The disclosure is material as it reflects significant operational challenges from a voluntary product recall and represents a material change in financial performance (net loss vs. prior-year net income).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-07T02:19:45.870686+00:00","company_name":"biote Corp.","ticker":"BTMD","filing_date":"2026-08-05"}]}